From: Does cystic fibrosis constitute an advantage in COVID-19 infection?
| Condition | Population | Mean (years) | Tested subjects (% of regional population) | COVID-19 cases | Rate of infection (% of regional population) | COVID-19 fatalities | CFR |
|---|---|---|---|---|---|---|---|
| General population | 4,907,704a | 45,4 | 465,433 (9.5%) | 19,729 | 0.40% | 2062 | 10.4% |
| CF population | 532 | 27,5 | 118 (22.2%) | 1 | 0.19% | 0 | – |